| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 03/14/1996 | WO1996007671A1 Racemization-free preparation of n-amino acid derivatives and dipeptides |
| 03/14/1996 | WO1996007670A1 Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces |
| 03/14/1996 | WO1996007435A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
| 03/14/1996 | DE19532495A1 Verfahren zum Reinigen von Hirudin A method for cleaning of hirudin |
| 03/14/1996 | CA2199387A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
| 03/14/1996 | CA2199248A1 Polymeric resin for disulfide bond synthesis |
| 03/14/1996 | CA2198898A1 Protective or anchor groups and their use |
| 03/13/1996 | EP0700933A1 Microsphere-based biotin-latex, process for the manufacture of such microspheres and use thereof as biological detecting agents |
| 03/13/1996 | EP0700927A1 A method of preparing L-aspartyl-D-alpha-aminoalkanecarboxylic acid-(S)-N-alpha-alkylbenzylamide |
| 03/13/1996 | EP0700522A1 Method for selection of biologically active peptide sequences |
| 03/13/1996 | EP0700447A1 Fluorescence energy transfer substrates |
| 03/13/1996 | EP0700300A1 Purification of plasma proteins |
| 03/13/1996 | EP0700295A1 Vitamin b 12? mediated oral delivery systems for gcsf and epo |
| 03/13/1996 | EP0516686B1 Separation by carrier mediated transport |
| 03/13/1996 | CN1118601A Inhibitors of herpes viral ribonucleotide reductase |
| 03/13/1996 | CN1031267C Compounds for anti-dementia medicine and its usage |
| 03/12/1996 | US5498728 Osteoporosis |
| 03/12/1996 | US5498698 Megakaryocyte potentiator |
| 03/12/1996 | EP0710245A4 Linear substituted oligoalkyleneimine libraries |
| 03/12/1996 | CA2053317C Active carbonates of polyalkylene oxides for modification of polypeptides |
| 03/12/1996 | CA1338163C Process for the preparation of n-alkylated dipeptides and their esters |
| 03/12/1996 | CA1338162C Process for the preparation of n-alkylated dipeptides and their esters |
| 03/10/1996 | CA2157811A1 Biotinylated latex microsphere; process for preparing the same and use thereof as a biological detector |
| 03/08/1996 | CA2157639A1 Method of preparing l-aspartyl-d-.alpha.-aminoalkanecarboxylic acid-(s)-n-.alpha.-alkylbenzylamide |
| 03/07/1996 | WO1996006860A2 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 03/07/1996 | WO1996006857A1 Immunostimulatory agents |
| 03/07/1996 | WO1996006855A1 NEW PEPTIDE DERIVATIVES WITH δ OPIOID RECEPTOR ANTAGONIST OR MIXED ν AGONIST/δ ANTAGONIST EFFECTS |
| 03/07/1996 | DE4431513A1 Racemisierungsfreie Herstellung und Verwendung von N-Methoxy- oder -Hydroxy-benzyl-Aminosäurederivaten und -Dipeptiden Racemization preparation and use of N-methoxy-benzyl or hydroxy-protected dipeptides and amino acid derivatives |
| 03/07/1996 | DE4431317A1 Schutz- bzw. Ankergruppen und deren Verwendung Protective or anchor groups and their use |
| 03/07/1996 | DE4431309A1 Preparative sepn. of macromolecules by gel-electrophoresis |
| 03/07/1996 | CA2198919A1 Gradual modification, super agonists and antagonists of signs and peptides |
| 03/07/1996 | CA2197566A1 New peptide derivatives with .delta. opioid receptor antagonist or mixed.mu. agonist/.delta. antagonist effects |
| 03/06/1996 | EP0699907A2 Diagnostic methods soluble CD8 T cell surface antigen and anti-CD8 antibody |
| 03/06/1996 | EP0699761A2 Heptaprenyl diphosphate synthesizing enzyme and dna encoding same |
| 03/06/1996 | EP0652769B1 Vaccines against metazoan parasites |
| 03/06/1996 | EP0479899B1 Vasodilatory and immune suppressant peptides |
| 03/06/1996 | CN1117974A Method for extracting antibody from yolk |
| 03/06/1996 | CN1117873A Usage of follicle-stimulating hormone |
| 03/06/1996 | CN1031193C Polypeptide and method for preparing same |
| 03/05/1996 | US5496802 Protein; antibody |
| 03/05/1996 | US5496724 Genes encoding platelet aggregation inhibitors |
| 03/05/1996 | US5496721 Methods of generating desired amino-terminal residues in proteins |
| 03/05/1996 | US5496554 Purified mite allergen |
| 03/05/1996 | CA1338122C Tissue factor inhibitor of coagulation |
| 02/29/1996 | WO1996006109A1 An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides |
| 02/29/1996 | WO1996005809A1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
| 02/28/1996 | EP0698616A1 Process for the preparation of a C1-esterase inhibitor (C1-1NH) concentrate and therapeutical use thereof |
| 02/28/1996 | EP0698615A1 Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions |
| 02/28/1996 | EP0698038A1 Method of separating glycosylated and non-glycosylated proteins |
| 02/28/1996 | EP0698037A1 Separation of anti-metal chelate antibodies |
| 02/28/1996 | EP0698036A1 Process for removing endotoxins |
| 02/28/1996 | EP0698035A1 Electrosynthetic method of modifying biomolecules in particular enzymes |
| 02/28/1996 | EP0697891A1 Polyoxime compounds and their preparation |
| 02/28/1996 | EP0697884A1 Ligand precursors for incorporation into peptides |
| 02/28/1996 | EP0362367B1 Osteogenic devices |
| 02/28/1996 | CN1117497A highly active vegetable anti-frozen protein, and separation tech. thereof |
| 02/27/1996 | US5494815 Polymer crosslinked by radiation or peroxide to form epoxide groups which react with substance to be immobilized; remaining epoxy groups stabilized with amine, carboxy or aminoacid components |
| 02/27/1996 | US5494807 NYVAC vaccinia virus recombinants comprising heterologous inserts |
| 02/27/1996 | US5494679 Molecules for iontophoretic delivery |
| 02/25/1996 | CA2692337A1 Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions |
| 02/22/1996 | WO1996005325A1 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
| 02/22/1996 | WO1996005219A1 Purified form of streptogramines, preparation thereof and pharmaceutical compositions containing it |
| 02/22/1996 | WO1996005214A1 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
| 02/22/1996 | WO1996004929A1 Antibacterial composition containing multimeric alpha-lactalbumin |
| 02/22/1996 | DE4430589A1 Soln. of inorganic salt in organic solvent or water as solvents |
| 02/22/1996 | CA2197420A1 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
| 02/21/1996 | EP0697023A1 3-(aminoacyl-amino)-saccharides and method for preparing them |
| 02/21/1996 | EP0560795B1 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them |
| 02/21/1996 | CN1117078A Low-cost extracting process for fermentation tailing liquor protein |
| 02/21/1996 | CN1117051A Anti-cancer active matter Huogu mushroom essence and its extracting process |
| 02/20/1996 | US5492896 Pseudopeptides having an antiviral action |
| 02/20/1996 | US5492834 Pretreating a clinical fluid with a size exclusion gel to remove interfering low molecular weight species |
| 02/20/1996 | US5492807 Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease |
| 02/20/1996 | CA2018211C Modified hvi-type hirudin and process for the manufacture thereof |
| 02/15/1996 | WO1996004297A1 Synthesis and use of amino acid fluorides as peptide coupling reagents |
| 02/15/1996 | WO1996000083A3 Method of isolating an antigene preparation |
| 02/15/1996 | DE3891231C2 Astigmatism correcting laser surgical set |
| 02/14/1996 | EP0696596A1 Detection, assay and isolation of compounds having the taxane ring skeleton |
| 02/14/1996 | EP0696578A2 Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or blockers of calcium channels |
| 02/14/1996 | EP0696427A1 Method for producing milk fraction having high emulsifying strength and product using the fraction |
| 02/14/1996 | CN1116628A Cyclopeptides of the formulal |
| 02/14/1996 | CN1116627A New peptides derived from trifluorumethylketones, process for their preparation and the pharmaceutical compositions which contain them |
| 02/14/1996 | CN1030988C Crystalline huma proinsulin and process for its production |
| 02/13/1996 | US5491129 Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them |
| 02/13/1996 | US5491128 Aglycons of A/16686 antibiotics |
| 02/13/1996 | US5491088 Genetic engineering |
| 02/13/1996 | US5491073 Cloning of chicken anaemia DNA |
| 02/13/1996 | US5490937 Purification, separation |
| 02/08/1996 | WO1996003651A1 Peptides marked with metal chelates |
| 02/08/1996 | WO1996003433A1 New process for the production of biologically active protein |
| 02/08/1996 | WO1996003432A1 Novel process for the production of biologically active dimeric protein |
| 02/08/1996 | WO1996003429A1 Stable analogs of bioactive peptides containing disulfide linkages |
| 02/08/1996 | WO1996003426A1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof |
| 02/08/1996 | WO1996003425A1 Process for folding of proteins like recombinant hirudin or epidermal growth factor |
| 02/08/1996 | WO1996003424A1 Combinatorial libraries of molecules and methods for producing same |
| 02/08/1996 | WO1996003423A1 Hapten-marked peptides |
| 02/08/1996 | WO1996003418A1 Soluble combinatorial libraries |
| 02/08/1996 | WO1996003212A1 Multidimensional conduit combinatorial library synthesis device |
| 02/08/1996 | WO1996003145A1 Influenza virus subunit conjugates |
| 02/08/1996 | CA2195648A1 Metal chelate-labelled peptides |